Elina Berliba

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis

William J. Sandborn, Marc Ferrante, Bal Raj Bhandari et al. · Gastroenterology · 2019 · 221 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis

William J. Sandborn, Marc Ferrante, Bal Raj Bhandari et al. · Clinical Gastroenterology and Hepatology · 2020 · 62 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis

Elina Berliba, Maxim Bogus, Frédéric Vanhoutte et al. · Antimicrobial Agents and Chemotherapy · 2019 · 45 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B

Man‐Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen et al. · Hepatology Communications · 2022 · 27 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

882 - Efficacy and Safety of Anti-Interleukin-23 Therapy with Mirikizumab (LY3074828) in Patients with Moderate-To-Severe Ulcerative Colitis in a Phase 2 Study

William J. Sandborn, Marc Ferrante, Bal Raj Bhandari et al. · Gastroenterology · 2018 · 19 citations

Veterinary Medicine, Immunology, Pharmacotherapy +16